CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Sep 09, 2024. (Total: 6293 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Next

Records 1-30 (of 58 Records)

Query Trace: Grosse S[original query]
Can incorporating molecular testing improve the accuracy of newborn screening for congenital adrenal hyperplasia? Sarafoglou K , Gaviglio A , Wolf C , Lorentz CP , Lteif A , Kyllo J , Radloff G , Detwiler Z , Cuthbert CD , Hodges JS , Grosse SD , Greene CN , Cordovado S . J Clin Endocrinol Metab 2024
CDC Grand Rounds: Newborn screening and improved outcomes. Howell RR , Terry S , Tait VF , Olney R , Hinton CF , Grosse S , Eichwald J , Cuthbert C , Popovic T , Glidewell J . MMWR Morb Mortal Wkly Rep 2012 61 (21) 390-3
Progress in expanding newborn screening in the United States Grosse SD , Cuthbert C , Gaffney M , Gaviglio A , Hinton CF , Kellar-Guenther Y , Kemper AR , McKasson S , Ojodu J , Riley C , Singh S , Sontag MK , Shapira SK . Am J Hum Genet 2023 110 (6) 1015-1016
Implementation of newborn screening for conditions in the United States first recommended during 2010-2018 Singh S , Ojodu J , Kemper AR , Lam WKK , Grosse SD . Int J Neonatal Screen 2023 9 (2)
Newborn screening for congenital hypothyroidism and phenylketonuria-beyond cost savings Grosse SD , Van Vliet G . J Pediatr 2023 258 113417
Correspondence on "Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions" by Lavelle et al. Grosse SD , Gudgeon JM . Genet Med 2022 24 (12) 2595-2596
Cost or price of sequencing? Implications for economic evaluations in genomic medicine. Grosse SD , Gudgeon JM . Genet Med 2021 23 (10) 1833-1835
Health and economic outcomes of newborn screening for infantile-onset Pompe disease. Richardson JS , Kemper AR , Grosse SD , Lam WKK , Rose AM , Ahmad A , Gebremariam A , Prosser LA . Genet Med 2020 23 (4) 758-766
Infants with Congenital Disorders Identified Through Newborn Screening - United States, 2015-2017. Sontag MK , Yusuf C , Grosse SD , Edelman S , Miller JI , McKasson S , Kellar-Guenther Y , Gaffney M , Hinton CF , Cuthbert C , Singh S , Ojodu J , Shapira SK . MMWR Morb Mortal Wkly Rep 2020 69 (36) 1265-1268
Ensuring the Life-Span Benefits of Newborn Screening. Kemper AR , Boyle CA , Brosco JP , Grosse SD . Pediatrics 2019 144 (6)
Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease. Prosser LA , Lam KK , Grosse SD , Casale M , Kemper AR . MDM Policy Pract 2018 2018 (1)
Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value? Grosse SD , Farnaes L . Genet Med 2018 21 (2) 269-271
Is universal tumor testing for Lynch syndrome cost-effective? It depends! Grosse SD . Genet Med 2018 21 (1) 252-253
Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations. Feng LB , Grosse SD , Green RF , Fink AK , Sawicki GS . Health Aff (Millwood) 2018 37 (5) 773-779
In Reference to: "Cost and Utility of Thrombophilia Testing". Berse B , Lynch JA , Bowen S , Grosse SD . J Hosp Med 2017 12 (9) 783
Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014. Chen Z , Kolor K , Grosse SD , Rodriguez JL , Lynch JA , Green RF , Dotson WD , Bowen MS , Khoury MJ . Genet Med 2017 20 (4) 428-434
BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014. Kolor K , Chen Z , Grosse SD , Rodriguez JL , Green RF , Dotson WD , Bowen MS , Lynch JA , Khoury MJ . MMWR Surveill Summ 2017 66 (15) 1-11
Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes. Grosse SD , Gurrin LC , Bertalli NA , Allen KJ . Genet Med 2017 20 (4) 383-389
Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1. Grosse SD , Lam WK , Wiggins LD , Kemper AR . Genet Med 2017 19 (9) 975-982
The need for a next-generation public health response to rare diseases. Valdez R , Grosse SD , Khoury MJ . Genet Med 2016 19 (5) 489-490
Epidemiology matters: peering inside the "black box" in economic evaluations of genetic testing. Grosse SD , Khoury MJ . Genet Med 2016 18 (10) 963-5
Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. Kemper AR , Brosco J , Comeau AM , Green NS , Grosse SD , Jones E , Kwon JM , Lam WK , Ojodu J , Prosser LA , Tanksley S . Genet Med 2016 19 (1) 121-126
Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State. Ding Y , Thompson JD , Kobrynski L , Ojodu J , Zarbalian G , Grosse SD . J Pediatr 2016 172 127-35
The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study. Karaceper MD , Chakraborty P , Coyle D , Wilson K , Kronick JB , Hawken S , Davies C , Brownell M , Dodds L , Feigenbaum A , Fell DB , Grosse SD , Guttmann A , Laberge AM , Mhanni A , Miller FA , Mitchell JJ , Nakhla M , Prasad C , Rockman-Greenberg C , Sparkes R , Wilson BJ , Potter BK . Orphanet J Rare Dis 2016 11 (1) 12
Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis. Grosse SD . Healthcare (Basel) 2015 3 (4) 1133-1157
Observed and expected frequencies of structural hemoglobin variants in newborn screening surveys in Africa and the Middle East: deviations from Hardy-Weinberg equilibrium. Piel FB , Adamkiewicz TV , Amendah D , Williams TN , Gupta S , Grosse SD . Genet Med 2015 18 (3) 265-74
When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives. Grosse SD . Healthcare (Basel) 2015 3 (4) 860-878
The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates. Grosse SD , Palomaki GE , Mvundura M , Hampel H . Genet Med 2015 17 (6) 510-1
Universal state newborn screening programs can reduce health disparities. Brosco JP , Grosse SD , Ross LF . JAMA Pediatr 2014 169 (1) 7-8
Mortality of New York children with sickle cell disease identified through newborn screening. Wang Y , Liu G , Caggana M , Kennedy J , Zimmerman R , Oyeku SO , Werner EM , Grant AM , Green NS , Grosse SD . Genet Med 2014 17 (6) 452-9